Nonetheless, this immune regulator receptor not only modulates tumor-associated inflammation and immune suppression, but also cross-signals cancer-associated pathways such as EGFR, PI3K, VEGF, NF-κB [22–24]. The gene discussed is NFKB1; the disease is cancer.